AU2015284640B2 - Methods and systems for interpretation and reporting of sequence-based genetic tests - Google Patents

Methods and systems for interpretation and reporting of sequence-based genetic tests Download PDF

Info

Publication number
AU2015284640B2
AU2015284640B2 AU2015284640A AU2015284640A AU2015284640B2 AU 2015284640 B2 AU2015284640 B2 AU 2015284640B2 AU 2015284640 A AU2015284640 A AU 2015284640A AU 2015284640 A AU2015284640 A AU 2015284640A AU 2015284640 B2 AU2015284640 B2 AU 2015284640B2
Authority
AU
Australia
Prior art keywords
information
patient
variant
knowledge base
clinical trial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015284640A
Other languages
English (en)
Other versions
AU2015284640A1 (en
Inventor
Douglas E Bassett Jr.
Daniel R. Richards
Peer M. Schatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiagen GmbH
Qiagen Redwood City Inc
Original Assignee
Qiagen GmbH
Qiagen Redwood City Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/319,986 external-priority patent/US10665328B2/en
Priority claimed from US14/460,568 external-priority patent/US10658073B2/en
Application filed by Qiagen GmbH, Qiagen Redwood City Inc filed Critical Qiagen GmbH
Publication of AU2015284640A1 publication Critical patent/AU2015284640A1/en
Assigned to QIAGEN GMBH, QIAGEN Redwood City, Inc. reassignment QIAGEN GMBH Amend patent request/document other than specification (104) Assignors: QIAGEN GMBH, QIAGEN Redwood City, Inc.
Application granted granted Critical
Publication of AU2015284640B2 publication Critical patent/AU2015284640B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
AU2015284640A 2014-06-30 2015-06-18 Methods and systems for interpretation and reporting of sequence-based genetic tests Active AU2015284640B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/319,986 US10665328B2 (en) 2014-06-30 2014-06-30 Methods and systems for interpretation and reporting of sequence-based genetic tests
US14/319,986 2014-06-30
US14/460,568 US10658073B2 (en) 2014-08-15 2014-08-15 Methods and systems for interpretation and reporting of sequence-based genetic tests using pooled allele statistics
US14/460,568 2014-08-15
PCT/US2015/036338 WO2016003660A1 (en) 2014-06-30 2015-06-18 Methods and systems for interpretation and reporting of sequence-based genetic tests

Publications (2)

Publication Number Publication Date
AU2015284640A1 AU2015284640A1 (en) 2017-01-19
AU2015284640B2 true AU2015284640B2 (en) 2021-01-28

Family

ID=53682785

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015284640A Active AU2015284640B2 (en) 2014-06-30 2015-06-18 Methods and systems for interpretation and reporting of sequence-based genetic tests

Country Status (6)

Country Link
EP (2) EP3916731A1 (https=)
JP (2) JP2017527050A (https=)
CN (1) CN106796620A (https=)
AU (1) AU2015284640B2 (https=)
CA (1) CA2953942C (https=)
WO (1) WO2016003660A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107533586A (zh) * 2015-03-23 2018-01-02 私有通道公司 用于加强生物信息学数据隐私和实现生物信息学数据广泛共享的系统、方法和设备
US20170242979A1 (en) * 2016-02-23 2017-08-24 Brody Holohan Method of performing clinical trials
US10719188B2 (en) 2016-07-21 2020-07-21 Palantir Technologies Inc. Cached database and synchronization system for providing dynamic linked panels in user interface
US10324609B2 (en) 2016-07-21 2019-06-18 Palantir Technologies Inc. System for providing dynamic linked panels in user interface
US12204845B2 (en) 2016-07-21 2025-01-21 Palantir Technologies Inc. Cached database and synchronization system for providing dynamic linked panels in user interface
US20190272907A1 (en) * 2016-09-21 2019-09-05 Agios Pharmaceuticals, Inc. Automated identification of potential drug safety events
GB201716305D0 (en) * 2017-10-05 2017-11-22 Palantir Technologies Inc Dashboard creation and management
US20200234801A1 (en) * 2017-10-06 2020-07-23 Koninklijke Philips N.V. Methods and systems for healthcare clinical trials
US11462299B2 (en) 2017-10-17 2022-10-04 Invitae Corporation Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
JP6953270B2 (ja) * 2017-10-19 2021-10-27 キヤノンメディカルシステムズ株式会社 病院情報システム、及び薬剤提案選出プログラム
CN108364692A (zh) * 2018-02-27 2018-08-03 北京盛诺家医院管理咨询有限公司 临床试验匹配方法及系统
JP6920251B2 (ja) * 2018-06-29 2021-08-18 シスメックス株式会社 解析方法、情報処理装置、プログラム
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
CN110164504B (zh) * 2019-05-27 2021-04-02 复旦大学附属儿科医院 二代测序数据的处理方法、装置及电子设备
WO2020249704A1 (en) * 2019-06-13 2020-12-17 F. Hoffmann-La Roche Ag Systems and methods with improved user interface for interpreting and visualizing longitudinal data
JP7177300B2 (ja) * 2019-10-21 2022-11-22 フラティロン ヘルス，インコーポレイテッド ゲノムテストステータスを特定するシステム及び方法
TWI849361B (zh) * 2020-12-03 2024-07-21 瑞士商諾華公司 實現跨不同資料庫的資料分析合作的平台及方法
CN112992298B (zh) * 2021-02-10 2022-07-12 北京声智科技有限公司 一种异常识别方法、试管关联人员确定方法及相关设备
CN113724806A (zh) * 2021-08-03 2021-11-30 邢传华 确定临床试验入组对象、适用药物的方法、设备和介质
CN113793638B (zh) * 2021-11-15 2022-03-25 北京橡鑫生物科技有限公司 一种同源重组修复基因变异的解读方法
JP2023080642A (ja) * 2021-11-30 2023-06-09 シスメックス株式会社 遺伝子変異の病原性の水準を報告するレポートを生成するレポート生成方法、及びレポート生成装置
US20230207071A1 (en) * 2021-12-29 2023-06-29 Microsoft Technology Licensing, Llc Knowledge-grounded complete criteria generation
US20240363198A1 (en) * 2023-04-27 2024-10-31 Cardiai Technologies System for identifying genetic variants and method thereof
US20250061987A1 (en) * 2023-08-17 2025-02-20 Helix, Inc. System that integrates genomic data and electronic health record (ehr) data in defining a cohort
CN119993368A (zh) * 2025-01-16 2025-05-13 广州道本信息科技有限公司 一种基于自然语言处理的病理基因检测报告生成系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013070634A1 (en) * 2011-11-07 2013-05-16 Ingenuity Systems, Inc. Methods and systems for identification of causal genomic variants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001188876A (ja) * 1999-12-28 2001-07-10 Hiroshi Saito 薬品の製造方法、薬品の試験評価システム、および薬品の試験評価方法
JP2002041657A (ja) * 2000-07-27 2002-02-08 Toyotaka Mori 総合治験管理システム
AU2001288410A1 (en) * 2000-08-28 2002-03-13 Patrick G. Morand Use of blood and plasma donor samples and data in the drug discovery process
JP2003108663A (ja) * 2001-09-28 2003-04-11 Gijutsu Transfer Service:Kk 治験情報管理システム、治験情報管理装置、治験情報管理方法、治験情報管理プログラム並びに記憶媒体
US20110113002A1 (en) * 2008-02-26 2011-05-12 Kane Michael D Method for patient genotyping
US20130218581A1 (en) * 2011-04-26 2013-08-22 Selventa, Inc. Stratifying patient populations through characterization of disease-driving signaling
EP2613278A2 (en) * 2011-12-05 2013-07-10 Koninklijke Philips Electronics N.V. Retroactive extraction of clinically relevant information from patient sequencing data for clinical decision support
WO2014063080A1 (en) * 2012-10-19 2014-04-24 Synta Pharmaceuticals Corp. Treating polycystic kidney disease with hsp90 inhibitory compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013070634A1 (en) * 2011-11-07 2013-05-16 Ingenuity Systems, Inc. Methods and systems for identification of causal genomic variants

Also Published As

Publication number Publication date
JP2020184371A (ja) 2020-11-12
EP3161698A1 (en) 2017-05-03
AU2015284640A1 (en) 2017-01-19
CN106796620A (zh) 2017-05-31
JP2017527050A (ja) 2017-09-14
EP3916731A1 (en) 2021-12-01
CA2953942C (en) 2023-10-03
JP7343453B2 (ja) 2023-09-12
CA2953942A1 (en) 2016-01-07
WO2016003660A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
US20200279620A1 (en) Methods and systems for interpretation and reporting of sequence-based genetic tests using pooled allele statistics
JP7343453B2 (ja) 配列に基づいた遺伝子検査の解釈および報告のための方法およびシステム
US20200279618A1 (en) Methods and systems for interpretation and reporting of sequence-based genetic tests
Nicora et al. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization
Fritsche et al. Cancer PRSweb: an online repository with polygenic risk scores for major cancer traits and their evaluation in two independent biobanks
Halu et al. The multiplex network of human diseases
US12051485B2 (en) Discovery routing systems and engines
Dingemans et al. PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework
US9785792B2 (en) Systems and methods for processing requests for genetic data based on client permission data
Jalali-Najafabadi et al. Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models
US20130166320A1 (en) Patient-centric information management
Cirulli et al. A power-based sliding window approach to evaluate the clinical impact of rare genetic variants in the nucleotide sequence or the spatial position of the folded protein
Zhang et al. Analysis of a novel therapeutic target and development of a prognostic model for primary glioblastoma based on ferroptosis-related genes
Crockett et al. Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting
Ghosh et al. Comorbidity patterns and its impact on health outcomes: two-way clustering analysis
Cooperstein et al. Phenotype-first patient matching with SimPheny identifies diagnostic candidates beyond curated gene associations
Tian et al. Identification of genes involved in breast cancer metastasis by integrating protein–protein interaction information with expression data
Lin et al. Multi-strategy feature selection and multi-model machine learning for prognostic prediction in primary gastric diffuse large B-cell lymphoma
Rockowitz et al. Scaling genomic reanalysis to unlock diagnoses and transform rare disease care
Ganakammal Utilization of Computational Approaches for Enhanced Assessment & Interpretation of Clinical Significance of Variants
Monroy-Iglesias et al. Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: QIAGEN GMBH

Free format text: FORMER NAME(S): QIAGEN REDWOOD CITY, INC.; QIAGEN GMBH

Owner name: QIAGEN REDWOOD CITY, INC.

Free format text: FORMER NAME(S): QIAGEN REDWOOD CITY, INC.; QIAGEN GMBH

FGA Letters patent sealed or granted (standard patent)